Cleared Traditional

K924257 - TESTOSTERONE SEROZYME(TM) ENZYME IMMUNOASSAY

K924257 is an FDA 510(k) clearance for TESTOSTERONE SEROZYME(TM) ENZYME IMMUNO..., manufactured by Serono-Baker Diagnostics, Inc.. The device is a Class 1 Chemistry device with product code CDZ cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K924257 · Serono-Baker Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1992
Decision
98d
Days
Class 1
Risk

K924257 is an FDA 510(k) clearance for the TESTOSTERONE SEROZYME(TM) ENZYME IMMUNOASSAY. Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Serono-Baker Diagnostics, Inc. (Allentown, US). The FDA issued a Cleared decision on November 30, 1992 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Serono-Baker Diagnostics, Inc. devices

FDA 510(k) Submission Details - K924257

510(k) Number K924257 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 1992
Decision Date November 30, 1992
Days to Decision 98 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 88d · This submission: 98d
Pathway characteristics
Predicate-based equivalence.

CDZ Device Classification - Class 1, General Controls

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 69
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K924257.
DELFIA SHBG KIT
K940449 · Wallac OY · Sep 1994
CIBA CORNING ACS TESTOSTERONE IMMUNOASSAY
K934562 · Ciba Corning Diagnostics Corp. · Dec 1993
DELFIA TESTTOSTERONE KIT
K932951 · Wallac OY · Aug 1993
DSL ACTIVE SHBG (DSL 7400)
K915823 · Diagnostic Systems Laboratories, Inc. · Mar 1992
SRI TESTOSTERONE ENZYME IMMUNOASSAY
K915164 · Serono-Baker Diagnostics, Inc. · Mar 1992
GAMMA COAT ASSAY TESTOSTERONE RADIOIMMUNOASSAY KIT
K915570 · Incstar Corp. · Jan 1992